Pages with the fewest revisions

From The School of Biomedical Sciences Wiki
Jump to: navigation, search

Showing below up to 500 results starting with #1.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Cytokinesis ‎(2 revisions)
  2. Oocyte ‎(2 revisions)
  3. Genomic DNA ‎(2 revisions)
  4. Polyploidy ‎(2 revisions)
  5. DNA methylase ‎(2 revisions)
  6. Hydroxide ‎(2 revisions)
  7. Ribonuceic acid ‎(2 revisions)
  8. Allostery ‎(2 revisions)
  9. Blastocyst ‎(2 revisions)
  10. Amoeba ‎(2 revisions)
  11. Dideoxy sequencing ‎(2 revisions)
  12. Growth hormone ‎(2 revisions)
  13. Interleukin 10 ‎(2 revisions)
  14. Personalised Healthcare ‎(2 revisions)
  15. Haworth projection ‎(2 revisions)
  16. Forward primer ‎(2 revisions)
  17. Memory B cell ‎(2 revisions)
  18. Phosphatidylethanolamine ‎(2 revisions)
  19. Threshold potential ‎(2 revisions)
  20. Consanguineous ‎(2 revisions)
  21. Herpes ‎(2 revisions)
  22. Kaposi's sarcoma ‎(2 revisions)
  23. Histone acetyltransferases ‎(2 revisions)
  24. Transition metal ‎(2 revisions)
  25. Current loops ‎(2 revisions)
  26. Caveolae ‎(2 revisions)
  27. Adipocyte ‎(2 revisions)
  28. D-isomer ‎(2 revisions)
  29. Light ‎(2 revisions)
  30. DNA template strand ‎(2 revisions)
  31. Dengue fever ‎(2 revisions)
  32. Immune complex ‎(2 revisions)
  33. SRY Gene ‎(2 revisions)
  34. Dilution formula ‎(2 revisions)
  35. HCN channel ‎(2 revisions)
  36. Scientific journals ‎(2 revisions)
  37. Filopodia ‎(2 revisions)
  38. Tetrasomy ‎(2 revisions)
  39. Complementary strand ‎(2 revisions)
  40. Heat shock protein ‎(2 revisions)
  41. Fructose ‎(2 revisions)
  42. Isoelectric point ‎(2 revisions)
  43. Thyroxine ‎(2 revisions)
  44. Ran ‎(2 revisions)
  45. Kidneys ‎(2 revisions)
  46. Atomic mass ‎(2 revisions)
  47. Transpeptidase ‎(2 revisions)
  48. Sphygmomanometer ‎(2 revisions)
  49. DNA Sequencing ‎(2 revisions)
  50. Chargaff's rule ‎(2 revisions)
  51. Glucocorticoid ‎(2 revisions)
  52. Pre-eclampsia ‎(2 revisions)
  53. Hypoxanthine ‎(2 revisions)
  54. Lymph fluid ‎(2 revisions)
  55. Amino acid residues ‎(2 revisions)
  56. Parasites ‎(2 revisions)
  57. Cisternae ‎(2 revisions)
  58. Grb2 ‎(2 revisions)
  59. Boiling point ‎(2 revisions)
  60. Fasciculi ‎(2 revisions)
  61. Macula densa ‎(2 revisions)
  62. Von Gierke disease ‎(2 revisions)
  63. Secretory vesicles ‎(2 revisions)
  64. Melanocytes ‎(2 revisions)
  65. 30S ‎(2 revisions)
  66. Hemophilus influenzae ‎(2 revisions)
  67. Α-D-glucopyranose ‎(2 revisions)
  68. Cosmid ‎(2 revisions)
  69. Lactate ‎(2 revisions)
  70. BRCA-1 ‎(2 revisions)
  71. Chemiluminescence ‎(2 revisions)
  72. Ribonuclease H ‎(2 revisions)
  73. Alopecia areata ‎(2 revisions)
  74. PI3Ka domain ‎(2 revisions)
  75. NAPQI ‎(2 revisions)
  76. Expect (E) value ‎(2 revisions)
  77. Lysis ‎(2 revisions)
  78. Clip ‎(2 revisions)
  79. Growth hormone releasing factor ‎(2 revisions)
  80. Nerve growth factor ‎(2 revisions)
  81. Brainstem ‎(2 revisions)
  82. Fermentation ‎(2 revisions)
  83. Anhydride ‎(2 revisions)
  84. Diuretics ‎(2 revisions)
  85. Sepsis ‎(2 revisions)
  86. X chromosomes ‎(2 revisions)
  87. Antihemophilic Factor ‎(2 revisions)
  88. Nucleous ‎(2 revisions)
  89. Cushing sydrome ‎(2 revisions)
  90. Cdk-activating kinase ‎(2 revisions)
  91. Molecular chaperone ‎(2 revisions)
  92. Polyacrylamide ‎(2 revisions)
  93. Trisomy 8 ‎(2 revisions)
  94. DATP ‎(2 revisions)
  95. Stationary phase ‎(2 revisions)
  96. Cerebellum ‎(2 revisions)
  97. Light dependent reaction ‎(2 revisions)
  98. Hypertrophy ‎(2 revisions)
  99. Best ‎(2 revisions)
  100. FAD ‎(2 revisions)
  101. Propyl ‎(2 revisions)
  102. Amylopectin ‎(2 revisions)
  103. Inorganic phosphate ‎(2 revisions)
  104. HDAC ‎(2 revisions)
  105. Filtrate ‎(2 revisions)
  106. Protien ‎(2 revisions)
  107. Wilson's Disease ‎(2 revisions)
  108. Anterior pituitary gland ‎(2 revisions)
  109. Intracellular receptors ‎(2 revisions)
  110. Phalanges ‎(2 revisions)
  111. Complementation ‎(2 revisions)
  112. Phospholipase A2 ‎(2 revisions)
  113. Small intestines ‎(2 revisions)
  114. Atomic number ‎(2 revisions)
  115. Oligonucleotide ‎(2 revisions)
  116. Replication forks ‎(2 revisions)
  117. BamH1 ‎(2 revisions)
  118. Lipophilic ‎(2 revisions)
  119. P13K ‎(2 revisions)
  120. N-acetylmuramic acid ‎(2 revisions)
  121. Lymph node ‎(2 revisions)
  122. In vitro ‎(2 revisions)
  123. Negative ion ‎(2 revisions)
  124. Mad cow disease ‎(2 revisions)
  125. Walter Gilbert ‎(2 revisions)
  126. Anaphase II ‎(2 revisions)
  127. Haemolysis ‎(2 revisions)
  128. Pulmonary artery ‎(2 revisions)
  129. Antibody-antigen complex ‎(2 revisions)
  130. Drug elimination ‎(2 revisions)
  131. Metaphase I ‎(2 revisions)
  132. Phosphoryl group ‎(2 revisions)
  133. Autocrine signalling ‎(2 revisions)
  134. Genomic library ‎(2 revisions)
  135. Stromatolites ‎(2 revisions)
  136. Chemiosmotic hypothesis ‎(2 revisions)
  137. Presynaptic modulation ‎(2 revisions)
  138. Ampere ‎(2 revisions)
  139. Dideoxyribose ‎(2 revisions)
  140. TFIIF ‎(2 revisions)
  141. Nerve impulse ‎(2 revisions)
  142. Mammography ‎(2 revisions)
  143. Weak acid ‎(2 revisions)
  144. Divalent metal ions ‎(2 revisions)
  145. Petri dish ‎(2 revisions)
  146. Compartmentalisation ‎(2 revisions)
  147. HeLa ‎(2 revisions)
  148. Nigrostriatal pathway ‎(2 revisions)
  149. Phosphatidylserine ‎(2 revisions)
  150. ABVD ‎(2 revisions)
  151. Carboxyl groups ‎(2 revisions)
  152. R group ‎(2 revisions)
  153. Physiotherapy ‎(2 revisions)
  154. Plant cells ‎(2 revisions)
  155. Transition state ‎(2 revisions)
  156. Celiac disease ‎(2 revisions)
  157. Molecular formula ‎(2 revisions)
  158. Postsynaptic membrane ‎(2 revisions)
  159. Oxidised ‎(2 revisions)
  160. Deoxygenated blood ‎(2 revisions)
  161. Synteny ‎(2 revisions)
  162. Chromosome walking ‎(2 revisions)
  163. FADH2 ‎(2 revisions)
  164. Dimers ‎(2 revisions)
  165. Inosine ‎(2 revisions)
  166. 'sticky' ends ‎(2 revisions)
  167. Complementation group ‎(2 revisions)
  168. Zellweger Syndrome ‎(2 revisions)
  169. Isoform ‎(2 revisions)
  170. Endoderm ‎(2 revisions)
  171. Plasmodium falciparum ‎(2 revisions)
  172. Transposable elements ‎(2 revisions)
  173. DNA Taq polymerase ‎(2 revisions)
  174. Orthophosphate ‎(2 revisions)
  175. Progesterone only pill ‎(2 revisions)
  176. Deuterium ‎(2 revisions)
  177. T-helper cell ‎(2 revisions)
  178. Citrate carries acetyl groups ‎(2 revisions)
  179. Fats ‎(2 revisions)
  180. Disease gene ‎(2 revisions)
  181. Cofactor ‎(2 revisions)
  182. Fluorine ‎(2 revisions)
  183. Pulmonary vein ‎(2 revisions)
  184. 3q22.1 ‎(2 revisions)
  185. Hepatitis B ‎(2 revisions)
  186. Electromagnetic spectrum ‎(2 revisions)
  187. Phosphorylase ‎(2 revisions)
  188. Coupled Pumps ‎(2 revisions)
  189. Gamma rays ‎(2 revisions)
  190. Trimeric G-proteins ‎(2 revisions)
  191. Humulin ‎(2 revisions)
  192. Morphine ‎(2 revisions)
  193. Hydroxyl groups ‎(2 revisions)
  194. Strong nuclear force ‎(2 revisions)
  195. Chemistry ‎(2 revisions)
  196. Uric acid ‎(2 revisions)
  197. PMAT ‎(2 revisions)
  198. Symptom ‎(2 revisions)
  199. Vimentin ‎(2 revisions)
  200. Diet ‎(2 revisions)
  201. Closed complex ‎(2 revisions)
  202. Nerve tissue ‎(2 revisions)
  203. Saturated hydrocarbon ‎(2 revisions)
  204. Mannose ‎(2 revisions)
  205. Tertiary structure ‎(2 revisions)
  206. Nitric Oxide ‎(2 revisions)
  207. Phosphlipid ‎(2 revisions)
  208. Heterocyclic ‎(2 revisions)
  209. Crick ‎(2 revisions)
  210. Acidity ‎(2 revisions)
  211. Reduction ‎(2 revisions)
  212. Trisomys ‎(2 revisions)
  213. DGTP ‎(2 revisions)
  214. Retinitis pigmentosa ‎(2 revisions)
  215. Equational Division ‎(2 revisions)
  216. Linear relationship ‎(2 revisions)
  217. Postsynaptic neurone ‎(2 revisions)
  218. Alkane ‎(2 revisions)
  219. Hypoglycaemia ‎(2 revisions)
  220. Oxidising agent ‎(2 revisions)
  221. Chimerism ‎(2 revisions)
  222. Amine ‎(2 revisions)
  223. Deoxynucleoside triphosphate ‎(2 revisions)
  224. Natural killer cells ‎(2 revisions)
  225. Prostacyclin ‎(2 revisions)
  226. Vitamins ‎(2 revisions)
  227. Anabolic ‎(2 revisions)
  228. Inositiol 1,4,5 triphosphate ‎(2 revisions)
  229. HINDIII ‎(2 revisions)
  230. Neuromuscular junctions ‎(2 revisions)
  231. C-terminus ‎(2 revisions)
  232. Megakaryocytes ‎(2 revisions)
  233. Intrinsic Pathway ‎(2 revisions)
  234. Complementation test ‎(2 revisions)
  235. Sex linkage ‎(2 revisions)
  236. Fugu Rubripes ‎(2 revisions)
  237. Metabolic processes ‎(2 revisions)
  238. Quiescence ‎(2 revisions)
  239. Isolating DNA ‎(2 revisions)
  240. G protein (Gs) ‎(2 revisions)
  241. Randomised controlled trials ‎(2 revisions)
  242. Recepter Tyrosine Kinases ‎(2 revisions)
  243. Endogenous ‎(2 revisions)
  244. Active immunity ‎(2 revisions)
  245. Charges ‎(2 revisions)
  246. Muscle Twitch ‎(2 revisions)
  247. Lipoprotein ‎(2 revisions)
  248. IGF (Insulin Growth Factor) ‎(2 revisions)
  249. Cholecystokinin ‎(2 revisions)
  250. Biochemistry ‎(2 revisions)
  251. Aminoacyl ‎(2 revisions)
  252. Incomplete dominance ‎(2 revisions)
  253. Parathyroid gland ‎(2 revisions)
  254. Citric Acid Cycle ‎(2 revisions)
  255. Gregory Mendel ‎(2 revisions)
  256. Protein coding genes ‎(2 revisions)
  257. Androgen ‎(2 revisions)
  258. Insulin receptor substrate ‎(2 revisions)
  259. Selenocysteine ‎(2 revisions)
  260. X-ray diffraction ‎(2 revisions)
  261. DsRNA ‎(2 revisions)
  262. Phosphatases ‎(2 revisions)
  263. Tracheotomy ‎(2 revisions)
  264. Histamine receptors ‎(2 revisions)
  265. Open state probability ‎(2 revisions)
  266. Centric fusion ‎(2 revisions)
  267. Restriction digests ‎(2 revisions)
  268. Aldose ‎(2 revisions)
  269. Hydroxylation ‎(2 revisions)
  270. Structural formula ‎(2 revisions)
  271. Primary alcohol ‎(2 revisions)
  272. Uridine ‎(2 revisions)
  273. Dehydration ‎(2 revisions)
  274. Promoters ‎(2 revisions)
  275. Patch clamp techniques ‎(2 revisions)
  276. Bromelain ‎(2 revisions)
  277. Protein sequence ‎(2 revisions)
  278. Animal cells ‎(2 revisions)
  279. Calcitonin ‎(2 revisions)
  280. Xenophagy ‎(2 revisions)
  281. Thymidine ‎(2 revisions)
  282. Rab ‎(2 revisions)
  283. Keratinocytes ‎(2 revisions)
  284. Cerebrum ‎(2 revisions)
  285. Multidrug resistance ‎(2 revisions)
  286. DNA transcription ‎(2 revisions)
  287. Chiral ‎(2 revisions)
  288. Valvular Heart Disease ‎(2 revisions)
  289. Amine group ‎(2 revisions)
  290. Deoxynucleotide ‎(2 revisions)
  291. Immunoblotting ‎(2 revisions)
  292. Synthetic ‎(2 revisions)
  293. Chronic myeloid leukaemia ‎(2 revisions)
  294. Anti-serum ‎(2 revisions)
  295. Pharmacokinetics ‎(2 revisions)
  296. Microtubule motor protein ‎(2 revisions)
  297. Endomembrane system ‎(2 revisions)
  298. Pleckstrin homology ‎(2 revisions)
  299. Cystic fibrosis transmembrane regulator ‎(2 revisions)
  300. Host cell ‎(2 revisions)
  301. Spindle assembly checkpoint ‎(2 revisions)
  302. Genetic sequence ‎(2 revisions)
  303. B-Lymphocyte ‎(2 revisions)
  304. Epidermal growth factor ‎(2 revisions)
  305. Tuberculin Test ‎(2 revisions)
  306. Hydrolytic enzymes ‎(2 revisions)
  307. Rous sarcoma ‎(2 revisions)
  308. Aminoacyl-tRNA synthase ‎(2 revisions)
  309. Induced Pluripotent stem cell ‎(2 revisions)
  310. T4 phage ‎(2 revisions)
  311. Fatty acid chain ‎(2 revisions)
  312. Protein crystallization ‎(2 revisions)
  313. Hairpin ‎(2 revisions)
  314. Neutrophils ‎(2 revisions)
  315. Self splicing ‎(2 revisions)
  316. Foetus ‎(2 revisions)
  317. Purine ‎(2 revisions)
  318. X-rays ‎(2 revisions)
  319. Non-sister chromatids ‎(2 revisions)
  320. Jejunum ‎(2 revisions)
  321. Catastrophe ‎(2 revisions)
  322. Recessive phenotype ‎(2 revisions)
  323. Staphylococci ‎(2 revisions)
  324. Positive charge ‎(2 revisions)
  325. Uridine Diphosphate Glucose (UDP-glucose) ‎(2 revisions)
  326. Virion ‎(2 revisions)
  327. Amphipathic molecule ‎(2 revisions)
  328. Fibroblast ‎(2 revisions)
  329. Serology ‎(2 revisions)
  330. Xenopus ‎(2 revisions)
  331. ADH ‎(2 revisions)
  332. Plaque ‎(2 revisions)
  333. Acromegaly ‎(2 revisions)
  334. Sperm ‎(2 revisions)
  335. Leaky junction ‎(2 revisions)
  336. Polygenic ‎(2 revisions)
  337. Van der Waals forces ‎(2 revisions)
  338. Nausea ‎(2 revisions)
  339. Voltage ‎(2 revisions)
  340. Tandem repeats ‎(2 revisions)
  341. Composition of prokaryotic ribosome ‎(2 revisions)
  342. Hematopoietic stem cells ‎(2 revisions)
  343. Sexual reproduction ‎(2 revisions)
  344. Efficacy ‎(2 revisions)
  345. Isomer ‎(2 revisions)
  346. High Altitude Cerebral Edema ‎(2 revisions)
  347. Enantiomers ‎(2 revisions)
  348. Mitochondrial ‎(2 revisions)
  349. Endometrium ‎(2 revisions)
  350. Genetic testing ‎(2 revisions)
  351. Resistance ‎(2 revisions)
  352. Polynucleotides ‎(2 revisions)
  353. Checkpoint pathways ‎(2 revisions)
  354. Glucose-1-phosphate ‎(2 revisions)
  355. Unipotent ‎(2 revisions)
  356. IL-6 ‎(2 revisions)
  357. P53 gene ‎(2 revisions)
  358. Surival Factors ‎(2 revisions)
  359. Rubidium ‎(2 revisions)
  360. Exonuclease ‎(2 revisions)
  361. Induced fit mechanism ‎(2 revisions)
  362. TATA-binding protein ‎(2 revisions)
  363. Group 1 metals ‎(2 revisions)
  364. Sanger Method ‎(2 revisions)
  365. Nick ‎(2 revisions)
  366. Purines ‎(2 revisions)
  367. Hepatocytes ‎(2 revisions)
  368. Non-steroidal anti-inflammatory drugs ‎(2 revisions)
  369. Phosphorylation cascade ‎(2 revisions)
  370. Histone ‎(2 revisions)
  371. OH group ‎(2 revisions)
  372. Catecholamines ‎(2 revisions)
  373. Reciprocal cross ‎(2 revisions)
  374. Optical isomer ‎(2 revisions)
  375. Epithelia ‎(2 revisions)
  376. Positive ion ‎(2 revisions)
  377. Alexander Fleming ‎(2 revisions)
  378. Urinary tract infection ‎(2 revisions)
  379. N terminal ‎(2 revisions)
  380. Extracellular fluid ‎(2 revisions)
  381. M. Musculus ‎(2 revisions)
  382. Complement ‎(2 revisions)
  383. Calcium 'Puffs' ‎(2 revisions)
  384. Pyruvate Kinase ‎(2 revisions)
  385. Xist ‎(2 revisions)
  386. Heteroplasmy ‎(2 revisions)
  387. Skeletal Muscle ‎(2 revisions)
  388. GLUT4 ‎(2 revisions)
  389. Kinetochores ‎(2 revisions)
  390. Moles ‎(2 revisions)
  391. Globin ‎(2 revisions)
  392. Sugar-phosphate backbone ‎(2 revisions)
  393. Evolutionary origin of chloroplasts and mitochondria ‎(2 revisions)
  394. ProSite ‎(2 revisions)
  395. Saccharomyces pombe ‎(2 revisions)
  396. Blunt end ‎(2 revisions)
  397. Prosthetic group ‎(2 revisions)
  398. Voltage-gated ion channel ‎(2 revisions)
  399. Meiosis II ‎(2 revisions)
  400. Protons ‎(2 revisions)
  401. Heme ‎(2 revisions)
  402. Non-Communicable Disease ‎(2 revisions)
  403. Egg cell ‎(2 revisions)
  404. Coronary Heart Disease ‎(2 revisions)
  405. Galactosemia ‎(2 revisions)
  406. Astrocytes ‎(2 revisions)
  407. Mitochondrial matrix ‎(2 revisions)
  408. Triamterene ‎(2 revisions)
  409. Cytidine triphosphate ‎(2 revisions)
  410. Housekeeping gene ‎(2 revisions)
  411. Spindle microtubles ‎(2 revisions)
  412. Epidermolysis bullosa simplex ‎(2 revisions)
  413. Leucocyte ‎(2 revisions)
  414. Streptococci ‎(2 revisions)
  415. Ethanal ‎(2 revisions)
  416. Pregnancy ‎(2 revisions)
  417. Daughter cell ‎(2 revisions)
  418. S-Phase ‎(2 revisions)
  419. Exonucleases ‎(2 revisions)
  420. Diakinesis ‎(2 revisions)
  421. Induced fit model ‎(2 revisions)
  422. Nephron ‎(2 revisions)
  423. Male ‎(2 revisions)
  424. Disulfide bond ‎(2 revisions)
  425. Tendon ‎(2 revisions)
  426. Nickase ‎(2 revisions)
  427. Semi-permeable membrane ‎(2 revisions)
  428. Thin layer chromatography ‎(2 revisions)
  429. Signalling ‎(2 revisions)
  430. Adensoine ‎(2 revisions)
  431. Optical isomerism ‎(2 revisions)
  432. Chemokines ‎(2 revisions)
  433. Ribosome intiation ‎(2 revisions)
  434. Imac chromatography ‎(2 revisions)
  435. Chromosome 17 ‎(2 revisions)
  436. Viruses ‎(2 revisions)
  437. Amphiphilic ‎(2 revisions)
  438. Innate Immune Response ‎(2 revisions)
  439. Anions ‎(2 revisions)
  440. Complementarity-determining regions ‎(2 revisions)
  441. Calcium channel ‎(2 revisions)
  442. GLUT5 ‎(2 revisions)
  443. Radiation ‎(2 revisions)
  444. Transgenic animal ‎(2 revisions)
  445. Okizaki fragment ‎(2 revisions)
  446. Monoamine neurotransmitters ‎(2 revisions)
  447. Leber's Hereditary Optic Neuropathy ‎(2 revisions)
  448. Troponin C ‎(2 revisions)
  449. Bacterial flagellum ‎(2 revisions)
  450. Alkyl group ‎(2 revisions)
  451. Rod cells ‎(2 revisions)
  452. Amino Acids ‎(2 revisions)
  453. Anaerobic ‎(2 revisions)
  454. The Patch Clamp Technique ‎(2 revisions)
  455. 100,000 genome project ‎(2 revisions)
  456. Heme biosynthetic pathway ‎(2 revisions)
  457. Phospholipid membrane ‎(2 revisions)
  458. Titration ‎(2 revisions)
  459. Ras pathway ‎(2 revisions)
  460. Asymmetric carbon ‎(2 revisions)
  461. Gastrointestinal tract ‎(2 revisions)
  462. Leucocytes ‎(2 revisions)
  463. Glucose 1-phosphate ‎(2 revisions)
  464. Unsaturated Fats ‎(2 revisions)
  465. Daughter cells ‎(2 revisions)
  466. Exosome ‎(2 revisions)
  467. Diamond ‎(2 revisions)
  468. Infection ‎(2 revisions)
  469. Classification ‎(2 revisions)
  470. Malignancy ‎(2 revisions)
  471. Watson-Crick pairs ‎(2 revisions)
  472. Tendons ‎(2 revisions)
  473. Semiconservative replication ‎(2 revisions)
  474. Follicle stimulating hormone ‎(2 revisions)
  475. XYY syndrome ‎(2 revisions)
  476. Thomas Cech ‎(2 revisions)
  477. Signalling cascade ‎(2 revisions)
  478. Carbon monoxide ‎(2 revisions)
  479. Joseph lister ‎(2 revisions)
  480. Subst ‎(2 revisions)
  481. Gluten ‎(2 revisions)
  482. Primer ‎(2 revisions)
  483. Aluminium ‎(2 revisions)
  484. Properties of Action Potentials ‎(2 revisions)
  485. Innate immune response ‎(2 revisions)
  486. Proteoglycan ‎(2 revisions)
  487. Domain ‎(2 revisions)
  488. Sertraline ‎(2 revisions)
  489. Y-linked disorders ‎(2 revisions)
  490. Antithrombin III ‎(2 revisions)
  491. EcoR1 ‎(2 revisions)
  492. Phosphoenolpyruvate ‎(2 revisions)
  493. Ketose ‎(2 revisions)
  494. Transgenic bacteria ‎(2 revisions)
  495. Acetyl group ‎(2 revisions)
  496. Endocrine glands ‎(2 revisions)
  497. Spermatozoa ‎(2 revisions)
  498. Enzyme-linked receptors ‎(2 revisions)
  499. Leber Congenital Amaurosis ‎(2 revisions)
  500. Aerobic ‎(2 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Personal tools
Namespaces
Variants
Views
Actions
Navigation
Toolbox